|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
FY2021
12 months to Apr 30, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales (exclusive of depreciation and amortization) | |||||
| Gross Profit, Total | |||||
| Operating expenses (income): | |||||
| Selling, general and administrative | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill | |||||
| Gain on sale of business | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Other (expense) income: | |||||
| Gain on legal settlement | |||||
| Interest expense | |||||
| Write-off of debt discount and deferred financing fees | |||||
| Other income, net | |||||
| Total other expense, net | |||||
| Income before taxes | |||||
| Provision for income taxes | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation adjustments | |||||
| Intra-entity transactions that are of a long-term investment nature, net of tax | |||||
| Changes in derivative financial instruments, net of tax | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive income | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Net income per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
Loading...